Related Experiment Video
Updated: Mar 25, 2026

12:06
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
22.9K
CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation.
Chen Li1, Cong Wang1, Yang Xing2
1Zhongshan Hospital of Fudan University, Shanghai, People's Republic of China.
Oncotarget
|February 25, 2016
Summary
CD133, a cancer stem cell marker, is highly expressed in gallbladder carcinoma (GBC) and promotes metastasis. Reducing CD133 inhibits GBC cell migration by affecting the Akt signaling pathway.
Area of Science:
- Oncology
- Gastroenterology
- Cancer Biology
Background:
- Gallbladder carcinoma (GBC) has a poor prognosis, often due to metastasis.
- Mechanisms driving GBC metastasis are not well understood.
- CD133 is a known cancer stem cell marker implicated in various cancers, including GBC.
Purpose of the Study:
- To investigate the role of CD133 in gallbladder carcinoma metastasis.
- To elucidate the molecular mechanisms by which CD133 influences GBC cell migration and invasion.
Main Methods:
- Comparative analysis of CD133 expression in GBC and normal tissues.
- Assessment of CD133's effect on GBC cell migration, invasion, and proliferation.
- Investigation of the Akt signaling pathway, including Akt phosphorylation and PTEN levels.
- Functional rescue experiments using Akt activators and inhibitors.
Main Results:
- CD133 is highly expressed in GBC, particularly in invasive areas.
- Down-regulation of CD133 significantly inhibited GBC cell migration and invasion without affecting proliferation.
- CD133 down-regulation led to decreased Akt phosphorylation and increased PTEN protein levels.
- Akt pathway modulation rescued or inhibited GBC cell migration.
Conclusions:
- CD133 plays a crucial role in promoting gallbladder carcinoma cell migration and invasion.
- The inhibitory effect of CD133 down-regulation on metastasis is mediated through the Akt signaling pathway.
- Targeting CD133 may offer a therapeutic strategy for inhibiting GBC progression.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
Cancer Cell Migration through Invadopodia
3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Intracellular Signaling Affects Focal Adhesions
3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.8K
MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Activation of Integrins
5.5K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.5K

